Transcription of Public Assessment Report - GOV.UK
{{id}} {{{paragraph}}}
Public Assessment Report Decentralised Procedure TETMODIS 25MG TABLETS. (TETRABENAZINE). UK/H/1816/001/DC. UK Licence No: PL 30414/0005. ORPHA-DEVEL HANDELS UND VERTRIEBS GMBH. PAR Tetmodis 25mg tablets UK/H/1816/001/DC. LAY SUMMARY. On 20th July 2010, the UK granted Orpha-Devel Handels und Vertriebs GmbH a Marketing Authorisation (licence) for Tetmodis 25mg tablets (PL 30414/0005; UK/H/1816/001/DC). These are prescription-only medicines (POM) for the treatment of diseases causing jerky, irregular, uncontrollable movements (hyperkinetic motor disorders with Huntington's chorea).
Public Assessment Report Decentralised Procedure TETMODIS 25MG TABLETS (TETRABENAZINE) UK/H/1816/001/DC UK Licence No: PL 30414/0005 ORPHA-DEVEL HANDELS UND VERTRIEBS GMBH
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}